InflaRx Presentation
Date:
Thursday, October 12
Time:
11:00AM – 11:15AM
Place:
Room 102 AB
Speaker:
Bruce Burnett, PhD
Topic:
The safety and efficacy advantage of blocking C5a vs. C5 in critically ill, COVID-19 patients: Results from PANAMO, a Phase 3 randomized controlled trial
<< back to list
